The loss of GluR2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer brains

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 9, 1997, Pages 1018-1027

  Ikonomovic, Milos D ^a   Mizukami, Katsuyoshi ^a,b   Davies, Peter ^c   Hamilton, Ronald ^d   Sheffield, Roxanne ^a   Armstrong, David M ^a,e  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^e Neurosciences Research Center   (United States)

Author keywords

Alzheimer; AMPA; Glutamate; Neurofibrillary tangles; Receptor; Tau

Indexed keywords

AMPA RECEPTOR; GLUTAMATE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DISEASE SEVERITY; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SENILE PLAQUE; SUBICULUM;

EID: 0030930206     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199709000-00007     Document Type: Article

References (38)

1. Choi DW. Excitotoxic cell death. J Neurobiol 1992;23(9):1261-76
2. Mattson MP. Calcium as sculptor and destroyer of neuronal circuitry. Exp Gerontol 1992;27:29-49
3. Khachaturian ZS. Calcium hypothesis of Alzheimer's disease and brain aging. Ann NY Acad Sci 1994;747:1-11
4. De Boni U, Crapper-McLachlan DR. Controlled induction of paired helical filaments of the Alzheimer type in cultured human neurons, by glutamate and aspartate. J Neurol Sci 1985;68:105-18
5. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung Y-C, Zaidi MS, Wisniewski HM. Microtubule-associated protein tau: A component of Alzheimer paired helical filaments. J Biol Chem 1986;261:6084-89
6. Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule associated protein tau in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986;83:4913-17
7. Lee VM-Y, Balin BJ, Otvos L Jr and Trojanowski JQ. A68: A major subunit of paired helical filaments and derivatized forms of normal tau. Science 1991;251:675-78
8. Mattson MP, Engle MG, Rychlik B. Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cortical neurons. Mol Chem Neuropathol 1991;15:117-42
9. 2+ in cultured hippocampal neurons. Neuron 1990;2:105-17
10. Choi DW. Glutamate receptors and the induction of excitotoxic neuronal death. In: Bloom F, ed. Progress in brain research. Elsevier Science, 1994;100:47-51
11. 2+ permeability of KA-AMPA-gated glutamate channels depends on subunit composition. Science 1991;252:851-53
12. Boulter J, Hollmann M, O'Shea-Greenfield A, et al. Molecular cloning and functional expression of glutamate receptor subunit genes. Science 1990;249:1033-37
13. Keinanen K, Wisden W, Sommer B, et al. A family of AMPA-selective glutamate receptors. Science 1990;249:556-60
14. Pellegrini-Giampietro DE, Zukin RS, Bennett MVL, Cho S, Pulsinelli WA. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc Natl Acad Sci USA 1992;89:10499-10503
15. Prince HK, Conn PJ, Blackstone CD, Huganir RL, Levey AI. Down-regulation of AMPA receptor subunit GluR2 in amygdaloid kindling. J Neurochem 1995;64:462-65
16. Armstrong DM, Ikonomovic MD, Sheffield R, Wenthold RJ. AMPA-selective glutamate receptor subtype immunoreactivity in the entorhinal cortex of non-demented elderly and patients with Alzheimer's disease. Brain Res 1994;639:207-16
17. Ikonomovic MD, Sheffield R, Armstrong DM. AMPA-selective glutamate receptor subtype immunoreactivity in the hippocampal formation of patients with Alzheimer's disease. Hippocampus 1995; 5:469-86
18. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
19. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assesment of Alzheimer's disease. Neurology 1991;41(4);479-86
20. Wenthold RJ, Yokotani N, Doi K, Wada K. Immunochemical characterization of the non-NMDA glutamate receptor using subunit-specific antibodies. J Biol Chem 1992;267:501-7
21. Weaver CL, Jicha GA, Vincent IJ, Davies P. Conformational and phosphorylated epitopes of tau in early Alzheimer's disease [abstract]. Soc Neurosci Abstr 1996;22:1421
22. Davies P, Zinkowski R, Kohnken R, et al. A sensitive and highly specific assay for PHF proteins [abstract]. Soc Neurosci Abstr 1996; 22:1422
23. Ikonomovic MD, Sheffield R, Armstrong DM. AMPA-selective glutamate receptor subtype immunoreactivity in the aged human hippocampal formation. J Comp Neurol 1995;359:239-52
24. Benzing WC, Ikonomovic MD, Brady DR, Mufson EJ, Armstrong DM. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease. J Comp Neurol 1993;334:176-91
25. Sindou P, Couratier P, Barthe D, Hugon J. A dose-dependent increase of Tau immunostaining is produced by glutamate toxicity in primary neuronal cultures. Brain Res 1992;572:242-46
26. Sautiere P-E, Sindou P, Couratier P, Hugon J, Wattez A, Delacourte A. Tau antigenic changes induced by glutamate in rat primary culture model: A biochemical approach. Neurosci Letters 1992;140: 206-10
27. Hugon J, Sindou P, Lesort M, Couratier P, Esclaire F, Yardin C. Modifications of phosphorylated tau immunoreactivity linked to excitotoxicity in neuronal cultures. In: Kosik KS, et al, eds. Alzheimer's disease: Lessons from cell biology. Berlin: Springer-Verlag, 1995:172-79
28. Couratier P, Sindou P, Tabaraud F, Diop AG, Spencer PS, Hugon J. Modulation of tau neuronal expression induced by NMDA, non-NMDA and metabotropic glutamate receptor agonists. Neurodegeneration 1995;4:33-41
29. Couratier P, Lesort M, Sindou P, Esclaire F, Yardin C, Hugon J. Modifications of neuronal phosphorylated tau immunoreactivity induced by NMDA toxicity. Mol Chem Neuropathol 1996;27:259-73
30. Trojanowski JQ, Lee VM-Y. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: Focusing on phosphatases. FASEB 1995;9:1570-76
31. Iqbal K, Alonso AdelC, Gong C-X, Khatoon S, Singh TJ, Grundke-Iqhal I. Mechanism of neurofibrillary degeneration in Alzheimer's disease. Mol Neurobiol 1994;9:119-23
32. Sholz WK, Palfrey HC. Glutamate-stimulated protein phosphorylation in cultured hippocampal pyramidal neurons. J Neurosci 1991; 11:2422-32
33. Garcia-Ladona FJ, Palacios JM, Probst A, Wieser HG, Mengod G. Excitatory amino acid AMPA receptor mRNA localization in several regions of normal and neurological disease affected human brain. An in situ hybridization histochemistry study. Mol Brain Res 1994;21:75-84
34. Brose N, Huntley GW, Stern-Bach Y, Sharma G, Morrison JH, Heinemann SF. Differential assembly of coexpressed glutamate receptor subunits in neurons of rat cerebral cortex. J Biol Chem 1994; 269:16780-84
35. Siegel SJ, Janssen WG, Tullai JW, et al. Distribution of the excitatory amino acid receptor subunits GluR2(4) in monkey hippocampus and colocalization with subunits GluR5-7 and NMDAR1. J Neurosci 1995;15:2707-19
36. Vickers JC, Huntley GW, Hof PR, Bederson J, DeFelipe J, Morrison JH. Immunocytochemical localization of non-NMDA ionotropic excitatory amino acid receptor subunits in human neocortex. Brain Res 1995;671:175-80
37. Hof PR, Vissavajjhala P, Rosenthal RE, Fiskum G, Morrison JH. Distribution of glutamate receptor subunit proteins GluR2(4), GluR5/6/7, and NMDAR1 in the canine and primate cerebral cortex: A comparative immunohistochemical analysis. Brain Res 1996; 723:77-89
38. 2+ influx underlies potent induction of injury. J Neurosci 1996;16(17):5457-65